Literature DB >> 17384334

Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis.

Gerlies Bock1, Elizabeth Chittilapilly, Rita Basu, Gianna Toffolo, Claudio Cobelli, Visvanathan Chandramouli, Bernard R Landau, Robert A Rizza.   

Abstract

OBJECTIVE: To determine the contribution of hepatic insulin resistance to the pathogenesis of impaired fasting glucose (IFG). RESEARCH DESIGN AND METHODS: Endogenous glucose production (EGP) and glucose disposal were measured in 31 subjects with IFG and 28 subjects with normal fasting glucose (NFG) after an overnight fast and during a clamp when endogenous secretion was inhibited with somatostatin and insulin infused at rates that approximated portal insulin concentrations present in IFG subjects after an overnight fast (approximately 80 pmol/l, "preprandial") or within 30 min of eating (approximately 300 pmol/l, "prandial").
RESULTS: Despite higher (P < 0.001) insulin and C-peptide concentrations and visceral fat (P < 0.05), fasting EGP and glucose disposal did not differ between IFG and NFG subjects, implying hepatic and extrahepatic insulin resistance. This was confirmed during preprandial insulin infusion when glucose disposal was lower (P < 0.05) and EGP higher (P < 0.05) in IFG than in NFG subjects. Higher EGP was due to increased (P < 0.05) rates of gluconeogenesis in IFG. EGP was comparably suppressed in IFG and NFG groups during prandial insulin infusion, indicating that hepatic insulin resistance was mild. Glucose disposal remained lower (P < 0.01) in IFG than in NFG subjects.
CONCLUSIONS: Hepatic and extrahepatic insulin resistance contribute to fasting hyperglycemia in IFG with the former being due at least in part to impaired insulin-induced suppression of gluconeogenesis. However, since hepatic insulin resistance is mild and near-maximal suppression of EGP occurs at portal insulin concentrations typically present in IFG subjects within 30 min of eating, extrahepatic (but not hepatic) insulin resistance coupled with accompanying defects in insulin secretion is the primary cause of postprandial hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17384334     DOI: 10.2337/db06-1776

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  70 in total

1.  Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes?

Authors:  Leigh Perreault; Bryan C Bergman; Mary C Playdon; Chiara Dalla Man; Claudio Cobelli; Robert H Eckel
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-06-03       Impact factor: 4.310

2.  Kaempferol ameliorates hyperglycemia through suppressing hepatic gluconeogenesis and enhancing hepatic insulin sensitivity in diet-induced obese mice.

Authors:  Hana Alkhalidy; Will Moore; Aihua Wang; Jing Luo; Ryan P McMillan; Yao Wang; Wei Zhen; Matthew W Hulver; Dongmin Liu
Journal:  J Nutr Biochem       Date:  2018-05-01       Impact factor: 6.048

Review 3.  Ten questions about systems biology.

Authors:  Michael J Joyner; Bente K Pedersen
Journal:  J Physiol       Date:  2011-01-04       Impact factor: 5.182

4.  Prediabetes linked to excess glucagon in transgenic mice with pancreatic active AKT1.

Authors:  Toya M Albury-Warren; Veethika Pandey; Lina P Spinel; Michal M Masternak; Deborah A Altomare
Journal:  J Endocrinol       Date:  2015-10-20       Impact factor: 4.286

5.  Strong association between insulin-mediated glucose uptake and the 2-hour, not the fasting plasma glucose concentration, in the normal glucose tolerance range.

Authors:  Diedre Winner; Luke Norton; Mustafa Kanat; Ruth Arya; Marcel Fourcaudot; Andrea Hansis-Diarte; Devjit Tripathy; Ralph A DeFronzo; Christopher P Jenkinson; Muhammad Abdul-Ghani
Journal:  J Clin Endocrinol Metab       Date:  2014-05-05       Impact factor: 5.958

6.  Mechanisms Underlying the Pathogenesis of Isolated Impaired Glucose Tolerance in Humans.

Authors:  Ron T Varghese; Chiara Dalla Man; Anu Sharma; Ivan Viegas; Cristina Barosa; Catia Marques; Meera Shah; John M Miles; Robert A Rizza; John G Jones; Claudio Cobelli; Adrian Vella
Journal:  J Clin Endocrinol Metab       Date:  2016-09-07       Impact factor: 5.958

Review 7.  Mechanisms of improved glucose handling after metabolic surgery: the big 6.

Authors:  Rebecca L Paszkiewicz; Richard N Bergman
Journal:  Surg Obes Relat Dis       Date:  2016-03-14       Impact factor: 4.734

8.  From pre-diabetes to type 2 diabetes in obese youth: pathophysiological characteristics along the spectrum of glucose dysregulation.

Authors:  Fida Bacha; Sojung Lee; Neslihan Gungor; Silva A Arslanian
Journal:  Diabetes Care       Date:  2010-06-30       Impact factor: 19.112

9.  Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy.

Authors:  Robert A Rizza
Journal:  Diabetes       Date:  2010-08-12       Impact factor: 9.461

10.  Modeling hepatic insulin sensitivity during a meal: validation against the euglycemic hyperinsulinemic clamp.

Authors:  Chiara Dalla Man; Francesca Piccinini; Rita Basu; Ananda Basu; Robert A Rizza; Claudio Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-02-26       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.